Keyphrases
Toll-like
100%
Lipopolysaccharide
100%
Thrombosis
100%
Antiphospholipid
100%
Antiphospholipid Syndrome
72%
Toll-like Receptor 4 (TLR4)
36%
Endothelial Cells
27%
Systemic Lupus Erythematosus
18%
Polymorphism
18%
Tissue Factor Expression
18%
Normal Human Serum
18%
Thr399Ile
18%
Asp299Gly
18%
Leukocytes
9%
Carotid Artery
9%
Pathogenic Role
9%
Affinity Column
9%
Massive Thrombus
9%
Thrombus
9%
Spontaneous mutation
9%
Endothelial Cell Activation
9%
Gene Polymorphism
9%
Venous Thrombosis
9%
Ethnic Origin
9%
Thrombogenic
9%
Cremaster muscle
9%
Allele-specific PCR
9%
Muscle Microcirculation
9%
Protected Polymorphism
9%
Biochemistry, Genetics and Molecular Biology
In Vivo Study
100%
Toll-Like Receptor
100%
Lipopolysaccharide
100%
Antiphospholipid Syndrome
72%
Leukocyte
18%
Normal Human
18%
TLR4
18%
Serum (Blood)
18%
Thromboplastin
18%
Homogenate
9%
Absorption
9%
Allele
9%
Gene Polymorphism
9%
Cell Activation
9%
Prevalence
9%
Spontaneous Mutation
9%
Microcirculation
9%
Phlebothrombosis
9%
Neuroscience
In Vivo
100%
Lipopolysaccharide
100%
Toll-Like Receptor
100%
Antiphospholipid Syndrome
72%
TLR 4
18%
Thromboplastin
18%
Systemic Lupus Erythematosus
18%
Leukocyte
18%
Thrombus
18%
DNA Polymorphism
9%
Cell Activation
9%
Cremaster Muscle
9%
Immunology and Microbiology
Antiphospholipid Syndrome
100%
Toll-Like Receptor
100%
Systemic Lupus Erythematosus
25%
TLR4
25%
Leukocyte
25%
Normal Human
25%
Serum (Blood)
25%
Thromboplastin
25%
Cell Activation
12%
Prevalence
12%
DNA Polymorphism
12%
Allele
12%
Homogenate
12%
Carotid Artery
12%
Absorption
12%
Microcirculation
12%
Spontaneous Mutation
12%
Cremaster Muscle
12%